Strategic Wealth Management »

Vertex Pharmaceuticals Incorporated shares owned by Strategic Wealth Management

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Strategic Wealth Management from 13F filings

Historical chart of Strategic Wealth Management investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Strategic Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Strategic Wealth Management

Quarter filed Position value Share count Share price at filing
2021-12-31 $1.1M 4.8k 219.58
2021-09-30 $885k 4.9k 181.32
2021-06-30 $986k 4.9k 201.68
2021-03-31 $1.0M 4.7k 214.79
2020-12-31 $1.1M 4.7k 236.31
2020-09-30 $1.3M 4.7k 272.15
2020-06-30 $1.5M 5.0k 290.40

More positions owned by Strategic Wealth Management

Schwab Strategic Tr Sht Tm Us Tres (SCHO)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Fs Kkr Capital Corp (FSK)
First Tr Exchange Traded Consumr Staple (FXG)
First Tr Exchange-traded Dj Internt Idx (FDN)
Spdr Gold Tr Gold Shs (GLD)
Exchange Traded Concepts Tr Emqq Em Intern (EMQQ)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Pimco Dynamic Income SHS (PDI)
Global X Fds Cloud Computng (CLOU)
Osi Etf Tr Oshs Gbl Inter
Ishares Tr Rus Mdcp Val Etf (IWS)
Ishares Tr U.s. Med Dvc Etf (IHI)
First Tr Exchange-traded First Tr Enh New (FTSM)
Advanced Micro Devices (AMD)

View all positions for Strategic Wealth Management

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
State Street Corporation
FMR
Capital Research Global Investors
Alliancebernstein
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Jennison Associates
Amundi
Loomis, Sayles and
Massachusetts Financial Services
Bank of America Corporation

View all funds holding Vertex Pharmaceuticals Incorporated